title: The impact of insulin treatment on the expression of vascular endothelial cadherin and Beta-catenin in human fetoplacental vessels.
abstract: Vascular endothelial cadherin and β-catenin play a key role in establishment and maintenance of the endothelial monolayer integrity, regulation of vascular barrier function, and initiation of angiogenesis. The cadherin-catenin complex has been shown to be reduced in type 1 diabetic placenta, but the exact relationship between histopathologic findings and clinical data is not known. Immunohistochemistry of placental tissue from type 1, type 2, and gestational diabetes showed that diabetes per se might be compatible with normal levels of vascular endothelial (VE)-cadherin and β-catenin in fetoplacental vessels as long as the patient has not been treated with insulin. Immunoreactivity of VE-cadherin did correlate poorly with maternal glycemic control, as was investigated in this study, by birth weight, body mass index, and hemoglobin A1c (HbA1c). There was no correlation found between the immunoreactivity of β-catenin and birth weight, body mass index, or HbA1c. However our data did show a strong correlation between immunoreactivity and whether or not the patient had been treated with insulin. Patients diagnosed with gestational diabetes who had not been treated with insulin had similar levels of VE-cadherin and β-catenin to the control group, thus indicating that diabetes per se must not necessarily lead to a reduction. Our study suggests that therapeutic intervention using insulin in pregnancies complicated by diabetes might have potentially harmful effects on placental morphology. Future studies should further investigate these findings.
authors.affiliation: 1 Department of Pediatric Pathology, University-Clinic of Bonn, Bonn, Germany.
authors.forename: Samira
authors.initials: S
authors.lastname: Baumüller
authors.forename: Harald
authors.initials: H
authors.lastname: Lehnen
authors.forename: Jörg
authors.initials: J
authors.lastname: Schmitz
authors.forename: Rolf
authors.initials: R
authors.lastname: Fimmers
authors.forename: Annette M
authors.initials: AM
authors.lastname: Müller
mesh_terms: D015703:Antigens, CD / Q000378:metabolism; D001724:Birth Weight; D015992:Body Mass Index; D015820:Cadherins / Q000378:metabolism*; D002824:Chorionic Villi / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000473:pathology*; D005260:Female; D005333:Fetus / Q000187:drug effects* / Q000378:metabolism; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D007328:Insulin / Q000627:therapeutic use*; D010920:Placenta / Q000187:drug effects* / Q000378:metabolism; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000378:metabolism; D014327:Trophoblasts / Q000378:metabolism; D051176:beta Catenin / Q000378:metabolism*; D000099152:Cadherin 5
chemical_list: D015703:Antigens, CD; D015820:Cadherins; D006442:Glycated Hemoglobin; D007328:Insulin; D051176:beta Catenin; D000099152:Cadherin 5; C495270:CTNNB1 protein, human; C517652:hemoglobin A1c protein, human
keywords: diabetes; endothelium; vascular endothelial cadherin; β-catenin